Company Cardiolrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx for Acute Myocarditis

Cardiol Therapeutics Inc. a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce that it has received approval from Health Canada to proceed with the Company's Phase II, multi-center, double-blind, randomized, placebo-controlled trial designed to study the safety and tolerability of CardiolRx™ as well .

United statesTrevor burnsCompany phaseCompany investigational new drugVascular instituteUniversity of pittsburgh medical centerDrug administrationVascular centerCompany annual information formCompany cardiolrxCardiol therapeutics incCompany onHealth canadaUniversity of ottawa heart instituteMcgill university health centreCardiol therapeutics

Cardiol Therapeutics Inc : Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis

Cardiol Therapeutics Inc : Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTrevor burnsDavid elsleyCompany investigational new drugVascular instituteUniversity of pittsburgh medical centerDrug administrationVascular centerCompany annual information formCompany cardiolrxCardiol therapeutics incNewsfile corpUniversity of ottawa heart instituteMcgill university health centreTherapeutics incInvestigational new drug

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

United statesTrevor burnsDavid elsleyCompany investigational new drugVascular instituteUniversity of pittsburgh medical centerDrug administrationVascular centerCompany annual information formCompany cardiolrxCardiol therapeutics incUniversity of ottawa heart instituteMcgill university health centreCardiol therapeuticsInvestigational new drugCleveland clinic